Abstract
Introduction. Dodecyl(3,5-dimethyl-4-hydroxybenzyl)sulfide (T1) and bis-[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propyl]sulfide (T2) are the collaborative development of Novosibirsk State Pedagogical University and Novosibirsk Research Institute of Antioxidants. It was revealed in several experiments and research works that these substances have antioxidant, anti-inflammatory, hepatoprotective, cytoprotective, haemorheological activities. These facts make the objects of study promising medicinal antioxidant drugs. Consequently it’s necessary for the future production quality control to have standards and analytical methods for substances analysis.Aim. Impurities methods development and validation for the new biologically active substances T1 and T2.Materials and methods. HPLC method with UV-detection on 278 nm was carried out for the determination of impurities in objects of study. HPLC analysis were performed on ZORBAX SB-C18 (5 μm, 150 × 4,6 mm) column with isocratic regimen and with use of the acetonitrile:water mixture (T1) or acetonitrile (T2) as a mobile phase.Results and discussion. It was find out, that T1 has two unidentified impurities with concentration not more than 0,1 % during the shelf life. The chromatogramm of T2 has a peak of by-product of synthesis T2 – bis-[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propyl]disulfide (T2-DS). Biologically safety of T2-DS was demonstrated in the previous works and the concentration of T2-DS was established to be not more, than 2,5 %. Furthermore, there was the one more unidentified impurity with concentration less, than 0,1 % on the chromatogram of T2. The developed HPLC methods were validated on characteristics «specificity», «linearity», «precision», «limit of quantification», «accuracy», «range».Conclusion. Methods for the determination of impurities in T1 and T2 were validated on the listed parameters. All the results meet the acceptance criteria: peaks on the chromatogramms are clearly separated; the correlation coefficients (r) are not more, than 0,980; accuracy was proved by linearity parameters; the value of the relative standard deviation is less, than 5 %; the intermediate precision for the both methods was proved by Fisher’s criterion and Student’s t-test.
Highlights
Dodecyl(3,5-dimethyl-4-hydroxybenzyl)sulfide (T1) and bis-[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propyl]sulfide (T2) are the collaborative development of Novosibirsk State Pedagogical University and Novosibirsk Research Institute of Antioxidants
HPLC analysis were performed on ZORBAX SB-C18 (5 μm, 150 × 4,6 mm) column with isocratic regimen and with use of the acetonitrile:water mixture (T1) or acetonitrile (T2) as a mobile phase
The chromatogramm of T2 has a peak of by-product of synthesis T2 – bis-[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propyl]disulfide (T2-DS)
Summary
Испытуемый раствор: Около 0,500 г (точная навеска) Т1 растворяют в 20 мл этанола и доводят объём этим же растворителем до 100,0 мл (5 мг/мл). Раствор сравнения: 1,0 мл испытуемого раствора доводят этанолом до 10,0 мл. Раствор для проверки пригодности хроматографической системы (Т1): 0,050 г гидрохинона помещают в мерную колбу вместимостью 200 мл, прибавляют 1 мл испытуемого раствора и 100 мл этанола, доводят объем раствора тем же растворителем до метки. Испытуемый раствор: Около 0,500 г (точная навеска) Т2 растворяют в 5мл ацетонитрила и доводят объём тем же растворителем до 25,0 мл. 1,0 мл полученного раствора доводят тем же растворителем до 100,0 мл (8 мкг/мл). Раствор сравнения В: 50 мг первичного стандартного образца бис-[3-(3,5ди-трет-бутил-4-гидроксифенил)пропил]дисульфида (далее пот тексту – ПТ2) растворяют в 5 мл ацетонитрила и доводят объём тем же растворителем до 25,0 мл. Условия хроматографирования объектов исследования методом ВЭЖХ представлены в таблице 1
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.